期刊文献+

替罗非班对急性ST段抬高型心肌梗死PCI术后心肌再灌注及心脏结构功能的影响 被引量:14

Clinical research of tirofiban afffected myocardial reperfusion,left ventricular remodeling and cardiac function in patients with acute ST-segment elevation myocardial infarction treated by percutaneous coronary intervention
原文传递
导出
摘要 随着操作技术的日益成熟和药物洗脱支架时代的到来,经皮冠状动脉介入治疗(PCI)已经成为指南推荐的急性ST段抬高型心肌梗死(STEAMI)首选的治疗措施,但是部分患者即使开通梗死相关血管(IRA),获得心肌溶栓试验(TIMI)血流分级3级,还会出现“无复流现象”。本文通过随机对照研究,探讨替罗非班对STEAMIPCI术后心肌灌注和左室重构及心功能的影响。
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第8期636-638,共3页 Chinese Journal of Practical Internal Medicine
关键词 替罗非班 心肌梗死 冠状动脉介入治疗 tirofiban myocardial infarction interventional therapy
  • 相关文献

参考文献3

  • 1Gibson CM, Cannon CP, Daley WL, et al. TIMI flame cunt : a quan- tilative method of assessing coronary flow [ J ]. Criculation, 1996, 93(5) :879 -888.
  • 2Morishima 1, Sone T, Okumura K, et al. Angiographie no-rflow phe- nonlenon as a predictor of adverse long-term outcome in patients treated with percutanoues transluminal coronary angioplasty for a- cute myocardial infarction[ J ]. J Am Coll Cardiol, 2000,36 ( 4 ) : 1202 - 1209.
  • 3Eeekhont E, Kern MJ. The coronary no-reflow phenomenon:a re- view of mechanism and therapies [ J]. Eur Heart J ,2001,22(9) : 729 - 739.

同被引文献99

  • 1陈明,郑博.2013美国ST段抬高心肌梗死指南解读[J].中国医学前沿杂志(电子版),2013,5(2):47-50. 被引量:8
  • 2张勇,杨春梅,刘积平,辛铭,张爽,闫立敏,刘桂华.小剂量尿激酶与低分子肝素钠联合治疗非ST段抬高心肌梗死疗效和安全性观察[J].武警医学,2004,15(10):773-774. 被引量:3
  • 3舒建中.参麦注射液对细胞凋亡影响的研究[J].实用中医内科杂志,2006,20(4):365-366. 被引量:1
  • 4解慧梅,胡格,索占伟,刘易通,尹龙,于同泉,路平,穆祥,黄会岭.人参皂甙Rb1和黄芪多糖对微血管内皮细胞分泌NO、IL-6和TNF-α的影响[J].畜牧兽医学报,2006,37(9):903-907. 被引量:23
  • 5Caliuto L,Robuzzi AG,Grea F.The no-reflow phenomenon[J].JaccCardovasc Imaging,2009,2(1):85-86.
  • 6栗冬梅.非ST段抬高型心肌梗死的分析[J].中西医结合心血管病杂志,2008,6(3):370-371.
  • 7Elmouchi DA,Bates ER.Platelet glycoproteinⅡb/Ⅲa inhibitortheropy in non-ST segment elevation acute coronary Syndromess[J].Minera cordioangiol,2003,51(5):547-560.
  • 8Sciahbasi A,Biondi-Zoccai G,Romagnoli E,et al.Routina upstreamversus selective down stream administration of glycoproteinⅡb/Ⅲa inhibitor in patients with non-ST-elevation acute coronarysyndromes[J].Int J cardiol,2010,10(9):1016-1025.
  • 9Peerlinck K,De lepeleire I,Goldberg M,et al.Mk-383(L-700462),a selective non peptide platebet glycoproteinⅡb/Ⅲa an-tagonist,it active in man[J].Circulation,1993,88(4Pt1):1512-1517.
  • 10Hernanides RS, Ottervanger JP, ten Berg JM, et al. Net clinical benefitof prehospital glycoprotein Ⅱb/Ⅲa inhibitors in patients with STelevationmyocardial infarction and high risk of bleeding: effectof tirofiban in patients at high risk of bleeding using CRUSADEbleeding score[J]. J Invasive Cardiol, 2012, 24(3): 84-89.

引证文献14

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部